SUBSCRIBE
SUBSCRIBE
News   Drug Development

Celltech Details Phase III Trial Plans For CDP870 In Crohn’s

October 19, 2005 | 
1 min read

A Phase III program in Crohn’s disease is under way to evaluate a compound being developed by Celltech Group plc.

Clinical research Phase 3 Europe
MORE ON THIS TOPIC
Insights
From Grants to Family Offices: Building a Unified Financing Strategy in Biotech
March 5, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Podcast
UniQure’s Delay, REGENXBIO’s Rejection Explained, Sarepta’s Ingram Steps Down, More
March 4, 2026
 · 
1 min read
 · 
Heather McKenzie
cloud with rain of coins on blue background. minimal concept of investment, success and cryptocurrencies. 3d rendering
Insights
Rethinking Biotech’s Valley of Death as Federal Grants and Family Offices Step In
March 4, 2026
 · 
3 min read
 · 
Jennifer Smith-Parker
IN PARTNERSHIP WITH MEDSIR
Webinar: The Future is Collaborative: Transforming Clinical Trials
March 3, 2026
 · 
1 min read
 · 
BioSpace Insights